Issue: February 2019
February 07, 2019
1 min read
Save

CONSERVE

Issue: February 2019
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers evaluated the safety, efficacy and cost efficiency of coronary CTA for stable patients without known CAD and a class II indication for non-emergent invasive coronary angiography (ICA).